These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2151416)

  • 41. New mechanisms for effects of anti-inflammatory glucocorticoids.
    Bailey JM
    Biofactors; 1991 Jun; 3(2):97-102. PubMed ID: 1832865
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lipocortins as antiphospholipase A2 and anti-inflammatory proteins.
    Russo-Marie F
    Adv Exp Med Biol; 1990; 279():197-210. PubMed ID: 2151415
    [No Abstract]   [Full Text] [Related]  

  • 43. Platelet activation--a role for a 40K anti-phospholipase A2 protein indistinguishable from lipocortin.
    Touqui L; Rothhut B; Shaw AM; Fradin A; Vargaftig BB; Russo-Marie F
    Nature; 1986 May 8-14; 321(6066):177-80. PubMed ID: 2939352
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Monoclonal antibodies specific to a Ca2(+)-bound form of lipocortin I distinguish its Ca2(+)-dependent phospholipid-binding ability from its ability to inhibit phospholipase A2.
    Hayashi H; Owada MK; Sonobe S; Domae K; Yamanouchi T; Kakunaga T; Kitajima Y; Yaoita H
    Biochem J; 1990 Aug; 269(3):709-15. PubMed ID: 2143895
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mutational analysis of the putative PLA2-inhibiting sequence of annexin 1.
    Travé G; Lees D; Liautard JP; Widada JS
    FEBS Lett; 1991 Nov; 293(1-2):34-6. PubMed ID: 1835701
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of lipocortin I in the glucocorticoid induction of the terminal differentiation of a human squamous carcinoma.
    Violette SM; King I; Browning JL; Pepinsky RB; Wallner BP; Sartorelli AC
    J Cell Physiol; 1990 Jan; 142(1):70-7. PubMed ID: 2137129
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dexamethasone-induced phospholipase A2-inhibitory proteins (PLIP) influenced by the H-2 histocompatibility region.
    Gupta C; Goldman AS
    Proc Soc Exp Biol Med; 1985 Jan; 178(1):29-35. PubMed ID: 3966074
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Phospholipase A2 and lipocortins, antiphospholipase proteins.
    Di Rosa M; Sautebin L; Carnuccio R
    Methods Enzymol; 1988; 163():23-31. PubMed ID: 2976871
    [No Abstract]   [Full Text] [Related]  

  • 49. Lipocortin.
    Flower R
    Biochem Soc Trans; 1989 Apr; 17(2):276-8. PubMed ID: 2526761
    [No Abstract]   [Full Text] [Related]  

  • 50. Uteroglobin inhibits phospholipase A2 activity.
    Levin SW; Butler JD; Schumacher UK; Wightman PD; Mukherjee AB
    Life Sci; 1986 May; 38(20):1813-9. PubMed ID: 3084897
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lipocortin-independent effect of dexamethasone on phospholipase activity in a thymic epithelial cell line.
    Piltch A; Sun L; Fava RA; Hayashi J
    Biochem J; 1989 Jul; 261(2):395-400. PubMed ID: 2528346
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Levels and localization of group II phospholipase A2 and annexin I in interleukin- and dexamethasone-treated rat mesangial cells: evidence against annexin mediation of the dexamethasone-induced inhibition of group II phospholipases A2.
    Vervoordeldonk MJ; Schalkwijk CG; Vishwanath BS; Aarsman AJ; van den Bosch H
    Biochim Biophys Acta; 1994 Dec; 1224(3):541-50. PubMed ID: 7803514
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Molecular biology of lipocortins: glucocorticoid-induced phospholipase A2 inhibitory proteins].
    Kawai S; Akama H; Ichikawa Y
    Nihon Rinsho; 1989 Oct; 47(10):2365-71. PubMed ID: 2532689
    [No Abstract]   [Full Text] [Related]  

  • 54. Cloning and expression of human lipocortin, a phospholipase A2 inhibitor with potential anti-inflammatory activity.
    Wallner BP; Mattaliano RJ; Hession C; Cate RL; Tizard R; Sinclair LK; Foeller C; Chow EP; Browing JL; Ramachandran KL
    Nature; 1986 Mar 6-12; 320(6057):77-81. PubMed ID: 2936963
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interaction of synthetic peptides from annexin I and uteroglobin with lipid monolayers and their effect on phospholipase A2 activity.
    Newman RH; Freemont PS; Barton GJ; Crumpton MJ
    Biochem Soc Trans; 1990 Dec; 18(6):1233-4. PubMed ID: 2150950
    [No Abstract]   [Full Text] [Related]  

  • 56. [Inhibitory effects of calphobindins on phospholipase A2 and phospholipase C].
    Utsumi T
    Nihon Sanka Fujinka Gakkai Zasshi; 1992 Jul; 44(7):793-9. PubMed ID: 1386868
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Uteroglobin: structure, molecular biology, and new perspectives on its function as a phospholipase A2 inhibitor.
    Miele L; Cordella-Miele E; Mukherjee AB
    Endocr Rev; 1987 Nov; 8(4):474-90. PubMed ID: 3319534
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lipocortins and phospholipase A2 regulation.
    Garcia MT; Zipfel M; Buhl WJ
    Biochem Soc Trans; 1990 Dec; 18(6):1231-2. PubMed ID: 2150949
    [No Abstract]   [Full Text] [Related]  

  • 59. Evaluation of the antiinflammatory and phospholipase-inhibitory activity of calpactin II/lipocortin I.
    Northup JK; Valentine-Braun KA; Johnson LK; Severson DL; Hollenberg MD
    J Clin Invest; 1988 Oct; 82(4):1347-52. PubMed ID: 2971676
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Regulation of phospholipase A2].
    Suwa Y
    Tanpakushitsu Kakusan Koso; 1991 Feb; 36(3):333-41. PubMed ID: 1827207
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.